Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) EBT Margin (2020 - 2025)

Historic EBT Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 12.58%.

  • Burning Rock Biotech's EBT Margin rose 150600.0% to 12.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.23%, marking a year-over-year increase of 619400.0%. This contributed to the annual value of 66.06% for FY2024, which is 551300.0% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's EBT Margin is 12.58%, which was up 150600.0% from 6.37% recorded in Q2 2025.
  • Burning Rock Biotech's EBT Margin's 5-year high stood at 6.37% during Q2 2025, with a 5-year trough of 200.29% in Q2 2022.
  • In the last 5 years, Burning Rock Biotech's EBT Margin had a median value of 133.09% in 2023 and averaged 110.56%.
  • As far as peak fluctuations go, Burning Rock Biotech's EBT Margin plummeted by -923200bps in 2021, and later surged by 1108700bps in 2023.
  • Over the past 5 years, Burning Rock Biotech's EBT Margin (Quarter) stood at 171.22% in 2021, then grew by 12bps to 150.68% in 2022, then rose by 12bps to 133.09% in 2023, then skyrocketed by 55bps to 60.29% in 2024, then skyrocketed by 79bps to 12.58% in 2025.
  • Its last three reported values are 12.58% in Q3 2025, 6.37% for Q2 2025, and 9.98% during Q1 2025.